Tablet
Latest McNeilab, Inc. Patents:
- 4-arylpiperazines and 4-arylpiperidines
- Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
- Cyclic benzylamino, benzylamido and benzylimido antipsychotic agents
- System for applying a heat shrinkable sleeve to a container
- Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-O-(1-methylethylidene)-.beta.-D-fructopyranose and (1-methylcyclohexyl)methanol
Description
FIG. 1 is a perspective view of a tablet showing my new design;
FIG. 2 is a top plan view thereof, the bottom plan view being a mirror image of that shown;
FIG. 3 is a front elevational view thereof;
FIG. 4 is a rear elevational view thereof; and
FIG. 5 is a right side elevational view thereof, the left side elevational view being a mirror image of that shown.
Referenced Cited
U.S. Patent Documents
Other references
D191003 | August 1961 | Miley |
D223759 | June 1972 | File |
D229175 | November 1973 | Libertone et al. |
D283931 | May 20, 1986 | Baum |
D286919 | November 25, 1986 | Flockhart et al. |
- Physicians' Desk Reference, 39th Edition, 1985, p. 431, published by Medical Economics Company Inc. American Pharmaceutical Association Academy of Pharmaceutical Sciences, 37th National Meeting and Premiere Exposition, Oct. 28-Nov. 1, 1984, "Roster of Advance Registrants". Zomax (zomepirac sodium) pamphlet from McNeilab, Inc. 1983.
Patent History
Patent number: D295683
Type: Grant
Filed: Aug 12, 1985
Date of Patent: May 10, 1988
Assignee: McNeilab, Inc. (Fort Washington, PA)
Inventor: John R. Kirk (McKeesport, PA)
Primary Examiner: James M. Gandy
Assistant Examiner: Kay H. Chin
Attorney: David J. Levy
Application Number: 6/764,807
Type: Grant
Filed: Aug 12, 1985
Date of Patent: May 10, 1988
Assignee: McNeilab, Inc. (Fort Washington, PA)
Inventor: John R. Kirk (McKeesport, PA)
Primary Examiner: James M. Gandy
Assistant Examiner: Kay H. Chin
Attorney: David J. Levy
Application Number: 6/764,807
Classifications
Current U.S. Class:
D28/2;
Jeweled (D28/81)